Publications by authors named "Ryo Kanai"

Introduction: Although the widespread use of screening tests and HPV vaccines for squamous cell carcinoma has led to early detection and treatment, effectiveness is limited for cervical adenocarcinoma. Lobular endocervical glandular hyperplasia (LEGH) corresponds to gastric metaplasia, but is regarded as a pathological condition with subtle morphological abnormalities. LEGH is a benign lesion and a precursor to gastric-type adenocarcinoma.

View Article and Find Full Text PDF
Article Synopsis
  • * In a study with ischemia reperfusion injury (IRI) rats, IFN-γ MSCs were found to significantly increase Treg cells and decrease inflammatory cell infiltration and renal fibrosis compared to regular MSCs.
  • * The study also revealed that the enhanced anti-inflammatory and anti-fibrotic effects of IFN-γ MSCs were linked to increased expression of indoleamine 2,3-dioxygenase (IDO), with IDO1 knockdown reducing
View Article and Find Full Text PDF
Article Synopsis
  • Lobular endocervical glandular hyperplasia (LEGH) is a benign lesion but can lead to gastric-type adenocarcinoma, highlighting the need for early diagnosis using specialized staining techniques and assays.
  • Researchers analyzed the nuclei of LEGH and endocervical (EC) cells using Gabor filter features to distinguish between them, achieving high accuracy with a linear support vector machine (LSVM).
  • Results showed that LEGH cell nuclei have milder gradient features compared to EC cell nuclei, suggesting a clear morphological distinction that aids in their classification.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on ARL4C, a protein highly expressed in colorectal cancer (CRC), which is linked to increased cell mobility, invasion, and growth.
  • Using a sensitive RNA detection method, researchers found that ARL4C was more prominently expressed at the invasion front of tumors and significantly associated with aggressive features like high-grade tumor budding and the epithelial-to-mesenchymal transition (EMT) phenotype.
  • The findings suggest that higher levels of ARL4C in both cancer cells and stromal cells may indicate a poorer prognosis for CRC patients, highlighting the need for further research on ARL4C's role in cancer progression.
View Article and Find Full Text PDF

Background And Objectives: Allergic transfusion reactions (ATRs) and febrile non-haemolytic transfusion reactions (FNHTRs) are common, although their mechanisms remain unclear. Immunoglobulin E (IgE)-mediated type I hypersensitivity may be involved in the pathogenesis of ATR. A basophil activation test (BAT) may help elucidate this process.

View Article and Find Full Text PDF

Background: Mesenchymal stem cells (MSCs) repair injured tissue in a paracrine manner. To enhance their therapeutic properties, preconditioning with various factors has been researched. We have previously showed that MSCs cultured in serum-free medium (SF-MSCs) promote their immunosuppressive ability, thereby enhancing their anti-fibrotic effect.

View Article and Find Full Text PDF
Article Synopsis
  • Mesenchymal stem cells (MSCs) show promise for treating acute kidney injury (AKI) and preventing it from progressing to chronic kidney disease (CKD).
  • In a study with rats, MSCs injected into the renal artery were more effective at reducing kidney damage compared to those injected via the inferior vena cava.
  • The renal artery injections allowed MSCs to persist longer in the injured kidneys, revealing changes in their localization and suggesting their antifibrotic benefits could be key in addressing kidney injury.
View Article and Find Full Text PDF
Article Synopsis
  • Mesenchymal stem cells (MSCs) can be activated by interferon-γ (IFN-γ) from natural killer cells, enhancing their anti-inflammatory effects, but this activation takes time, causing delays in therapeutic benefits.
  • In a study with rats suffering from ischemia-reperfusion injury and unilateral ureter obstruction, MSCs pretreated with IFN-γ were more effective in reducing inflammation and fibrosis compared to untreated MSCs.
  • The increased secretion of prostaglandin E2 from IFN-γ-treated MSCs played a crucial role in their anti-fibrotic effects by promoting the polarization of immune cells, indicating that IFN-γ pretreatment could
View Article and Find Full Text PDF

Background: Lobular endocervical glandular hyperplasia (LEGH) is a disease considered to be the origin of tumorigenesis of minimal deviation adenocarcinoma, which has characteristic expression in the gastric pyloric mucosa. It is difficult to diagnose by nuclear findings because of lower nuclear atypia. In this study, nuclei of endocervical (EC) and LEGH cells were digitized, and nuclear information was quantified from nuclear images and objectively evaluated using a computer.

View Article and Find Full Text PDF

Background: Mesenchymal stem cells (MSCs) have been reported to promote the regeneration of injured tissue via their paracrine abilities, which are enhanced by hypoxic preconditioning. In this study, we examined the therapeutic efficacy of hypoxia-preconditioned MSCs on renal fibrosis and inflammation in rats with ischemia-reperfusion injury (IRI).

Methods: MSCs derived from rats and humans were incubated in 1% O conditions (1%O MSCs) for 24 h.

View Article and Find Full Text PDF

Background: Lobular endocervical glandular hyperplasia (LEGH) was first described by Nucci et al. in 1999 and is believed to be a precancerous lesion of minimal deviation adenocarcinoma and gastric-type adenocarcinoma in the uterine cervix. LEGH lesions do not always exhibit apparent cellular and structural atypia, so are difficult to distinguish from normal endocervical cells (EC cells) with cytological examination.

View Article and Find Full Text PDF

In organisms other than higher plants, family 19 chitinase was first discovered in Streptomyces griseus HUT6037, and later, the general occurrence of this enzyme in Streptomyces species was demonstrated. In the present study, the distribution of family 19 chitinases in the class Actinobacteria and the phylogenetic relationship of Actinobacteria family 19 chitinases with family 19 chitinases of other organisms were investigated. Forty-nine strains were chosen to cover almost all the suborders of the class Actinobacteria, and chitinase production was examined.

View Article and Find Full Text PDF

Chitinase C from Streptomyces griseus HUT6037, described in 1997, is the first family 19 chitinase found in an organism other than higher plants. In this study, some properties of chitinase C were compared with those of family 18 bacterial chitinases, and the distribution of family 19 chitinases in Streptomyces species was investigated. The specific hydrolysing activity of chitinase C against soluble and insoluble chitinous substrates was markedly higher than those of bacterial family 18 chitinases.

View Article and Find Full Text PDF